Head to head

OptimasMAX vs Venus Versa (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: No new-price range is on file for either OptimasMAX or Venus Versa. Request current quotes to compare purchase costs.
Practice fit: OptimasMAX: IPL/RF platform. Venus Versa: body contouring. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL/RF platform

View full device profile →

Device B

Body Contouring

View full device profile →

Price comparison

Price comparison: InMode OptimasMAX vs Venus Versa
Attribute	InMode OptimasMAX	Venus Versa
New price range	Not published	Not published
Used price reference	Not published	$20k–$45kSource not documented
Payback calculator	View cost details	View ROI calculator
Next step

New price range

InMode OptimasMAX: Not published
Venus Versa: Not published

Used price reference

InMode OptimasMAX: Not published
Venus Versa: $20k–$45kSource not documented

Payback calculator

InMode OptimasMAX: View cost details
Venus Versa: View ROI calculator

Next step

InMode OptimasMAX

Venus Versa

Supplies & running costs

Supplies & running costs: InMode OptimasMAX vs Venus Versa
Attribute	InMode OptimasMAX	Venus Versa
Supplies & restrictions	Supply details not yet documented. View running-cost details	Supply pricing is not documented with a dated source yet. Request an itemized supply quote. Supply restrictions: soft-lock (defeatable) — internal shot-count chip, resettable by third-party refurbishers View running-cost details

Supplies & restrictions

InMode OptimasMAX: Supply details not yet documented.
View running-cost details
Venus Versa: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Supply restrictions: soft-lock (defeatable) — internal shot-count chip, resettable by third-party refurbishers
View running-cost details

FDA status & indications

FDA status & indications: InMode OptimasMAX vs Venus Versa
Attribute	InMode OptimasMAX	Venus Versa
FDA status & indication	FDA record cited — see scopeK251632 Record scope: 510(k): K251632 (decision 26 Jun 2025). Checked 4 Sep 2026. Read FDA indication wording “The Optimas MAX System with the Diolaze XL MAX is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The Fusion Light and the Fusion Dark are intended for hair removal. The Optimas MAX System with the VasculazeMAX is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The Optimas MAX System with the Lumecca Peak Applicators are indicated for use for the following treatments: * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); * The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, superficial leg veins and venous malformations. The Optimas MAX System with the Plus and Forma Handpieces are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation The Optimas MAX System with the he Morpheus8 Applicators is intended for use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 Applicator is limited to Skin Types I-IV.”	FDA ClearedK153717 Read FDA indication wording “The Venus Versa System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

FDA status & indication

InMode OptimasMAX: FDA record cited — see scopeK251632
Record scope: 510(k): K251632 (decision 26 Jun 2025). Checked 4 Sep 2026.
Read FDA indication wording
“The Optimas MAX System with the Diolaze XL MAX is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. The Fusion Light and the Fusion Dark are intended for hair removal. The Optimas MAX System with the VasculazeMAX is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The Optimas MAX System with the Lumecca Peak Applicators are indicated for use for the following treatments: * The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); * The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikiloderma of Civatte, superficial leg veins and venous malformations. The Optimas MAX System with the Plus and Forma Handpieces are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation The Optimas MAX System with the he Morpheus8 Applicators is intended for use in dermatologic procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 Applicator is limited to Skin Types I-IV.”
Venus Versa: FDA ClearedK153717
Read FDA indication wording
“The Venus Versa System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.”

Which chains run each

Which chains run each: InMode OptimasMAX vs Venus Versa
Attribute	InMode OptimasMAX	Venus Versa
Chain adoption	0 recorded pairings	1 recorded pairing
Chains using it	—	Formula Wellness(Confirmed)
Approved reviews	0	0

Chain adoption

InMode OptimasMAX: 0 recorded pairings
Venus Versa: 1 recorded pairing

Chains using it

InMode OptimasMAX: —
Venus Versa: Formula Wellness(Confirmed)

Approved reviews

InMode OptimasMAX: 0
Venus Versa: 0

Specs and platform

Specs and platform: InMode OptimasMAX vs Venus Versa
Attribute	InMode OptimasMAX	Venus Versa
Manufacturer	InMode	Venus Concept
Built by (OEM)	InMode Ltd.	Venus Concept Inc.
Category	IPL/RF platform	Body Contouring
Technology	Multi-application IPL and RF platform (IPL)	Multi-application platform w/ body RF (IPL)
Launch year	—	2016
Status	Current	Current
Manufacturing relationship evidence	No separate manufacturing-relationship record linked.	No separate manufacturing-relationship record linked.

Manufacturer

InMode OptimasMAX: InMode
Venus Versa: Venus Concept

Built by (OEM)

InMode OptimasMAX: InMode Ltd.
Venus Versa: Venus Concept Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cynosure FlexSure

RF body contouring

New-equipment price not yet documented.

DEKA Onda Coolwaves

RF body contouring

New-equipment price reference

$100k–$150k

Source not documented

Check the profile for configuration and price details.

EndyMed PRO

RF body contouring

New-equipment price reference

$50k–$80k

Source not documented

Check the profile for configuration and price details.

InMode BodyFX / MiniFX (Contoura)

RF body contouring

New-equipment price reference

$90k–$140k

Source not documented

Check the profile for configuration and price details.

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.